Chips Carry the Nasdaq to a Fresh Record as the Post-Holiday Tape Diverges

The first trading day after the July 4 holiday produced one of the cleaner opening snapshots of the year: a semiconductor complex in full rebound, a Nasdaq-100 at a new record high, and a healthcare sector heading the other direction. The question is whether this is the start of a durable broadening—or a last gasp of narrow AI-chip leadership before the Fed’s removed easing bias catches up with valuations.

The Chip Rebound in Numbers

The VanEck Semiconductor ETF (SMH) gained 3.36% to $612.20, while the broader Technology Select Sector SPDR (XLK) rose 2.42% to $184.96. Those moves dwarfed the S&P 500’s 0.80% advance to $750.75 and left the Dow Jones Industrial Average essentially flat at $527.88.{{cite:0e9d8f414c77}}

The individual semiconductor names tell a more vivid story:

{{cite:91c9f05f6f5b}}

The Nasdaq-100 (QQQ) closed at $725.18, up 1.76%, while the Russell 2000 (IWM) gained 0.84% to $300.09—a sign that small-caps participated, though modestly.{{cite:0e9d8f414c77}} The Nasdaq Composite reportedly closed at a record 26,018.82, up 0.72%.{{cite:27598f457041}}

What Powered the Rebound: Memory and the $650 Billion Floor

The immediate catalyst was a wave of analyst upgrades focused on the memory-chip supply picture. UBS projected that the DRAM market will remain undersupplied until at least 2028, reinforcing what it called a supercycle. Citi placed Micron on a 90-day upside catalyst watch with higher average selling price growth estimates, and Bank of America reiterated its Buy rating on Micron citing elevated memory share of AI infrastructure spending.{{cite:72592aeaa2d5}}

Micron’s own management has been emphatic. CEO Sanjay Mehrotra warned in late June that supply shortages in memory and storage will take considerable time to ease, with no clear view on when production will match surging demand even by 2028.{{cite:db44cf71bfdf}} The company has also signed 16 strategic customer agreements locking in floor prices at margins it says are “well above our peak quarterly margins in any past cycle” for five years.{{cite:db44cf71bfdf}}

Layered on top was JPMorgan’s Mid-Year Outlook 2026, published today, which doubled down on chipmakers as a core thesis. The bank raised hyperscaler capital expenditure projections by $130 billion for 2026, bringing total projected spending to over $650 billion through year-end, and named Broadcom a Strong Buy based on an AI chip backlog where orders exceed current fill capacity.{{cite:3433d860efcb}}

JPMorgan analyst Harlan Sur’s team acknowledged this is not a zero-risk trade. The bank specifically flagged the narrowing valuation gap between chipmakers and the hyperscalers themselves as a risk factor—when semiconductor companies trade at multiples rivaling the platforms buying their products, the margin of safety shrinks.{{cite:3433d860efcb}}

That is the tension a balanced reading has to hold. The supply-side case is concrete: multi-year customer agreements, a CEO publicly warning of shortages past 2028, and $650 billion in committed hyperscaler spending. What would have to be true for the bear case? Spending commitments get revised down—something quarterly capex guidance from Microsoft, Google, Amazon, and Meta would reveal before any macro indicator does.

Tesla’s Delivery Beat: Buy the Rumor, Sell the News—Then Buy Again

Tesla surged 5.48% to $415.00, the largest single-name move among mega-caps.{{cite:0e9d8f414c77}} The gain came despite—or perhaps because of—a convoluted reaction to its Q2 delivery report released last week. Tesla delivered 480,126 vehicles in the second quarter, a 25% year-over-year increase and roughly 74,000 vehicles above the Wall Street consensus of approximately 406,000.{{cite:46fda88c88fe}} It was Tesla’s strongest second quarter ever and its first year-over-year delivery growth after two straight years of decline.{{cite:46fda88c88fe}}

Yet shares fell more than 7% on the day of the delivery beat last week, marking Tesla’s worst single-day slide in about a year.{{cite:df55365d7404}} The pattern was textbook “buy the rumor, sell the news.” Today’s 5.48% rebound suggests some of that selling was overdone—or at least that the post-holiday risk-on mood is extending to the name.

The underlying picture is mixed. Cox Automotive data showed a 20% year-over-year decline in US deliveries in Q2, while European registration data indicated roughly 57% growth through the first five months and China sales have been on an eight-month growth streak.{{cite:df55365d7404}} Rival BYD delivered 557,090 vehicles in the same quarter, trouncing Tesla, with overseas sales up more than 94% in June.{{cite:df55365d7404}} Even with the rebound, Tesla is on pace for roughly 1.7 million deliveries this year—still below its 2023 peak of 1.8 million.{{cite:df55365d7404}}

The Divergence: Healthcare Breaks Lower

While tech surged, the Health Care Select Sector SPDR (XLV) fell 1.50% to $161.29—the worst-performing major sector ETF on the day.{{cite:0e9d8f414c77}} The damage was broad:

• MRK (Merck): −2.69% to $126.07
• UNH (UnitedHealth): −2.30% to $415.58
• JNJ (Johnson & Johnson): −2.18% to $257.30
• LLY (Eli Lilly): −1.45% to $1,196.35

{{cite:91c9f05f6f5b}}

The healthcare decline comes after a period where XLV had been gaining ground—closing the holiday week near a record as Lilly’s GLP-1 dominance drove the sector.{{cite:c82fb07840d7}} Today’s pullback could be simple sector rotation as capital rotates toward the chip rebound, or it could reflect something more structural. With the Fed signaling higher-for-longer and consumer sentiment in freefall, defensive sectors face a contradictory setup: demand for healthcare is relatively inelastic, but policy and pricing pressure on drugmakers and insurers is intensifying.

Notably, Microsoft (MSFT) also declined 1.24% to $385.65—the only mega-cap tech name in the red—suggesting that even within tech, the rally is concentrated in the AI-infrastructure supply chain rather than the hyperscaler buyers themselves.{{cite:0e9d8f414c77}}

The Fed Backdrop: A Central Bank That Removed Its Easing Bias

The chip rally is unfolding against a monetary policy backdrop that is considerably less friendly than the VIX of 16.59 suggests.{{cite:99a656ea19ab}}

At the June 16–17 FOMC meeting—Kevin Warsh’s first as chairman—the committee voted unanimously to hold the federal funds rate at 3.50%–3.75%. But the statement was slashed to 130 words from 341 and removed all language indicating a bias toward future cuts. The dot plot erased the prior outlook for a rate cut this year and pushed any reductions into 2027 and 2028, with the median year-end projection rising to 3.8%—above the current range, signaling that a hike is on the table.{{cite:513425362274}}

The inflation backdrop driving that shift: CPI inflation at 4.17% year-over-year as of the latest reading, well above the Fed’s 2% target, partly reflecting supply shocks from the Middle East conflict that have driven energy price increases.{{cite:99a656ea19ab}} The FOMC raised its 2026 inflation forecast to 3.6% headline and 3.3% core, up sharply from 2.7% for both in March.{{cite:513425362274}}

Kalshi’s prediction market for the July 29 Fed decision prices a 91% chance of a hold and an 8% chance of a hike, with a cut effectively off the table at 1%.{{cite:76b20f107c1a}} Fed minutes from the June meeting are scheduled for release this week, and they will be dissected for any detail on the nine committee members who anticipate at least one hike this year versus the eight who expect no change.{{cite:27598f457041}}

The Macro Tension: Resilient Growth vs. Collapsing Sentiment

The macro snapshot contains a contradiction worth watching. Real GDP is growing at 2.66% year-over-year, industrial production is up 1.67%, and unemployment is a low 4.2%.{{cite:99a656ea19ab}} By hard-data measures, the economy is expanding at a solid pace—the Fed’s own statement acknowledged as much.{{cite:513425362274}}

Yet the University of Michigan Consumer Sentiment index fell to 44.8, down 14.18% year-over-year and 10.04% month-over-month.{{cite:99a656ea19ab}} That is not a minor wobble—it is one of the lowest readings in the series’ history and a deterioration that, if sustained, typically precedes a consumer spending pullback. The hard data and the soft data are pointing in different directions, and the gap between them is the kind of thing that resolves one way or the other within a few quarters.

The FRED macro analog search returns mid-2006 as the closest historical match, with a similarity score of 0.95.{{cite:99a656ea19ab}} In that period, unemployment was 4.6–4.7%, CPI inflation ran at 3.9–4.1%, and the economy was not yet in recession—but it was roughly 18 months away from one. The yield curve was slightly inverted in mid-2006; today it is positively sloped at +0.35% on the 10s-2s spread, which is a meaningful difference.{{cite:99a656ea19ab}} The analog is not a forecast, but it is a reminder that resilient growth and elevated inflation at the late stage of a cycle can coexist for longer than expected—and that the break, when it comes, often arrives from the direction sentiment is pointing, not the direction GDP is pointing.

A Balanced Read

Here is what each side of this market needs to be true.

For the bulls: The $650 billion in hyperscaler capex is committed and visible, memory supply is structurally constrained through 2028, and the chip backlog provides revenue visibility that justifies current valuations. The Fed may be on hold for longer, but GDP growth of 2.66% and a VIX of 16.59 mean financial conditions remain accommodative enough for risk assets. The healthcare pullback is rotation, not a warning.

For the bears: The Fed has removed its easing bias and nine of eighteen dot-plot participants see a hike this year. Consumer sentiment at 44.8 is screaming that something is wrong at the household level even if it has not shown up in payrolls yet. The chip-to-hyperscaler valuation gap is narrowing—JPMorgan’s own risk flag—and Microsoft’s decline today suggests the buyers of chips are not participating in the rally their suppliers are enjoying. The mid-2006 analog says the current mix of resilient growth and elevated inflation can persist for a while, but not indefinitely.

The honest assessment is that both cannot be fully right. The chip supply story is real and well-documented. The Fed pivot is also real and well-documented. Which one matters more for equity returns over the next two quarters depends on whether consumer sentiment is a leading indicator of a growth slowdown that forces the Fed’s hand—or just a sentiment gauge distorted by political and energy-price noise.

What to Watch Next

• Fed minutes (this week): The June FOMC minutes will reveal the internal debate behind the unanimous hold and the removed easing bias. Any detail on the nine members expecting a hike versus the eight expecting no change will move rate-sensitive names.
• Q2 earnings season: Begins in earnest this month. Hyperscaler capex guidance from Microsoft, Google, Amazon, and Meta is the real-time barometer for whether JPMorgan’s $650 billion thesis is holding.
• Consumer sentiment revision: The preliminary July reading will show whether June’s drop to 44.8 was a one-month shock or the start of a trend. A second leg down would put the hard-data/soft-data contradiction in sharper relief.
• Healthcare sector flows: Whether XLV’s 1.50% decline is a one-day rotation or the start of a sustained outflow will indicate whether capital is rotating toward chips or away from defensives for a reason.
• Tesla’s Model Y L launch: The US rollout of the three-row Model Y L is Tesla’s next catalyst for reversing its 20% US delivery decline. Watch whether it moves the US sales trajectory in July and August registration data.
• Micron and memory pricing: Quarterly updates from Micron on DRAM ASPs and the 16 strategic customer agreements will test whether the floor-price structure holds as new fab capacity comes online in 2027–2028.